-+ 0.00%
-+ 0.00%
-+ 0.00%

SAGIMET’S LICENSE PARTNER ASCLETIS ANNOUNCED ACCEPTANCE OF NEW DRUG APPLICATION FOR DENIFANSTAT FOR THE TREATMENT OF MODERATE TO SEVERE ACNE BY CHINA’S NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Reuters·12/10/2025 12:03:43

Please log in to view news